Antipsychotics Flashcards
Traditional (First generation)
Fluphenazine (Prolixin)
Chlorpromazine (Thorazine)
Haloperidol (Haldol)
Z*endaya is a DOL
Traditional (First generation) SE
Increased EPS (extrapyramidal symptoms)
Increased NMS (neuroleptic malignant syndrome)
Anticholinergic effects
Atypical (Second generation)
Clozapine (Clozaril) — Agranulocytosis! WBC <3,500/mm3
Olanzapine (Zyprexa)
Quetiapine (Seroquel)
Ziprasidone (Geodon)
Risperidone (Risperidol)
Atypical (Second generation) SE
Increased metabolic syndrome
Decreased EPS/NMS
Sexual side effects
Orthostatic hypotension
Anticholinergic side effects
Atypical (Third generation)
Aripiprazole (Abilify)
Available in LONG-ACTING DEPOT INJECTIONS:
Fluphenazine
Haloperidol
Olanzapine
Risperidone
Anticholinergic (tx of EPS)
Benztropine (Cogentin)
Diphenhydramine (Benadryl)
EPS Symptoms
- Acute Dystonia: severe spasms of tongue, neck, face and back
- Pseudoparkinsonism: bradykinesia, rigidity, shuffling gait, drooling, tremors
- Akathisia: inability to sit still, pacing, agitation
- Tardive dyskinesia: involuntary movements of tongue and face, lip smacking, worm-like movements of the tongue, involuntary movements of arms, leg, trunk. Can be permanent.
(PRN benztropine or diphenhydramine)
NMS symptoms
- Usually manifests after initial exposure or abrupt discontinuation of antipsychotic medications.
- First generation/traditional - particularly haloperidol, carry a higher risk of developing NMS.
- Nursing considerations for a client who is experiencing NMS include immediately discontinuing the antipsychotic, monitoring fluid and electrolytes, initiating cooling measures, and placing the client on cardiac monitoring
The acronym FEVER can be used to help memorize the manifestations of NMS:
Fever
Encephalopathy
Vital sign instability
Elevated creatine kinase
Rigidity (Lead pipe rigidity)
Depot Injections
Helps with medication adherence
Fluphenazine, Haloperidol, Olanzapine
Monitor 3 hrs after injection for adverse reactions
Lasts 3-4 weeks
Clozapine
-Requires monitoring of WBC for potentially fatal agranulocytosis
-Notify provider of indications of infection: fever, sore throat, mouth lesions
-Nurse should immediately contact the health care provider if the client’s WBC value is less than 3,500/mm3
-Weekly, biweekly and then monthly
Sublingual tablets
Oral disintegrating tablets are prescribed for those who have difficulty swallowing or might “Cheek” medication
Olanzapine
Metabolic syndrome
Second Generation antipsychotics have increased risk of Metabolic Syndrome (SE)
-increased levels of blood sugar
-increased blood pressure
-increased cholesterol
-Weight gain
Monitor clients who are high risk of developing type 2 diabetes mellitus or previously diagnosed with diabetes
monitor blood glucose and lipid levels
*B.B.C for W